Cargando…
Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
BACKGROUND: The use of tocolytics is central in delaying birth; however, therapeutic options vary in effectiveness and adverse events profiles, which in turn could have consequences for medical resource use and cost of treatment. Betamimetics are commonly used tocolytic agents, but their mechanism o...
Autores principales: | Wex, Jaro, Connolly, Mark, Rath, Werner |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708127/ https://www.ncbi.nlm.nih.gov/pubmed/19538754 http://dx.doi.org/10.1186/1471-2393-9-23 |
Ejemplares similares
-
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)
por: van Vliet, Elvira OG, et al.
Publicado: (2014) -
Management of preterm labor: atosiban or nifedipine?
por: de Heus, Roel, et al.
Publicado: (2010) -
Hexoprenaline Compared with Atosiban as Tocolytic Treatment for Preterm Labor
por: Kirchhoff, Ebba, et al.
Publicado: (2022) -
Short-Term Outcomes of Atosiban in the Treatment of Preterm Labour at the Sultan Qaboos University Hospital, Muscat, Oman: A tertiary care experience
por: Al-Riyami, Nihal, et al.
Publicado: (2021) -
Critical appraisal and clinical utility of atosiban in the management of preterm labor
por: Sanu, Olaleye, et al.
Publicado: (2010)